SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer

PURPOSE: To determine the optimal dose and schedule of anthracycline and taxane administration as adjuvant therapy for early-stage breast cancer. PATIENTS AND METHODS: A 2 × 2 factorial design was used to test two hypotheses: (1) that a novel continuous schedule of doxorubicin-cyclophosphamide was s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Budd, George T., Barlow, William E., Moore, Halle C.F., Hobday, Timothy J., Stewart, James A., Isaacs, Claudine, Salim, Muhammad, Cho, Jonathan K., Rinn, Kristine J., Albain, Kathy S., Chew, Helen K., Burton, Gary V., Moore, Timothy D., Srkalovic, Gordan, McGregor, Bradley A., Flaherty, Lawrence E., Livingston, Robert B., Lew, Danika L., Gralow, Julie R., Hortobagyi, Gabriel N.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2015
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4268253/
https://ncbi.nlm.nih.gov/pubmed/25422488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.56.3296
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados